|
Financial Information Relating to Operating Segments (Detail) (USD $)
In Thousands, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2010
|
|
| Segment Reporting Information [Line Items] | |||
| External sales | $ 314,560 | $ 289,962 | $ 269,047 |
| Earnings before income taxes | 162,195 | 164,981 | 156,446 |
| Goodwill | 85,682 | 86,633 | 25,068 |
| Intangible assets, net | 46,476 | 52,282 | 2,044 |
| Assets | 719,324 | 617,670 | 518,816 |
| Depreciation and amortization | 12,467 | 8,700 | 8,130 |
| Capital purchases | 6,017 | 3,630 | 4,644 |
|
Biotechnology
|
|||
| Segment Reporting Information [Line Items] | |||
| External sales | 293,274 | 270,287 | 250,653 |
| Earnings before income taxes | 162,763 | 164,332 | 155,989 |
| Goodwill | 85,682 | 86,633 | 25,068 |
| Intangible assets, net | 46,476 | 52,282 | 2,044 |
| Assets | 529,392 | 505,087 | 400,112 |
| Depreciation and amortization | 10,920 | 7,165 | 5,411 |
| Capital purchases | 4,021 | 2,707 | 3,885 |
|
Hematology
|
|||
| Segment Reporting Information [Line Items] | |||
| External sales | 21,286 | 19,675 | 18,394 |
| Earnings before income taxes | 8,002 | 7,222 | 6,869 |
| Goodwill | 0 | 0 | 0 |
| Intangible assets, net | 0 | 0 | 0 |
| Assets | 22,135 | 21,046 | 18,543 |
| Depreciation and amortization | 411 | 417 | 340 |
| Capital purchases | 597 | 149 | 208 |
|
Reportable Segment
|
|||
| Segment Reporting Information [Line Items] | |||
| Earnings before income taxes | 170,765 | 171,554 | 162,858 |
| Assets | 551,527 | 526,133 | 418,655 |
| Depreciation and amortization | 11,331 | 7,582 | 5,751 |
| Capital purchases | 4,618 | 2,856 | 4,093 |
|
Unallocated Amount to Segment
|
|||
| Segment Reporting Information [Line Items] | |||
| Earnings before income taxes | (8,570) | (6,573) | (6,412) |
| Assets | 167,797 | 91,537 | 100,161 |
| Depreciation and amortization | 1,136 | 1,118 | 2,379 |
| Capital purchases | $ 1,399 | $ 774 | $ 551 |
| X | ||||||||||
|
- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Carrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquiree, adjusted for any amortization recognized prior to the adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|